Swedish Orphan Biovitrum: all 135 studies
Page 2 of 2. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.
- Kineret CAPS Post Authorisation StudyCompletedNCT02326376
- Efficacy and Safety of Once Daily Dosing Compared to Twice Daily Dosing of Nitisinone in HT-1CompletedNCT02323529Phase 3
- Long Term Safety Study of Orfadin Treatment in HT-1 Patients in Standard Clinical CareCompletedNCT02320084
- Safety and Tolerability of SOBI002 in Healthy Volunteers Following Single and Repeated AdministrationTerminatedNCT02083666Phase 1
- A Non-interventional Retrospective Study of the Current Treatment Practice in European Haemophilia CareCompletedNCT02049099
- Crossover Trial of the Effect of a High-Fat Meal on the PK of Oral CHR 2797 in Healthy Male SubjectsCompletedNCT01638442Phase 1
- Pharmacokinetic and Safety Study of Pixantrone in Patients With Metastatic Cancer and Hepatic ImpairmentWithdrawnNCT01632436Phase 1
- First in Human Study of an Anti-IFN Gamma Monoclonal Antibody in Healthy VolunteersCompletedNCT01459562Phase 1
- Comparison of rhBSSL With Placebo When Added to Infant Formula or Pasteurized Breast Milk During 4 Weeks of Treatment in Preterm InfantsTerminatedNCT01413581Phase 3
- Characterization of Cyanocobalamin in Healthy Voluteers After Intranasal and Intramuscual AdministrationCompletedNCT01306123Phase 1
- Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Pasteurized Breast Milk for Preterm InfantsCompletedNCT00659243Phase 2
- Efficacy and Safety of Bile Salt Stimulated Lipase (BSSL) as Replacement Therapy in Infant Formula for Preterm InfantsCompletedNCT00658905Phase 2
- Fludarabine, Pixantrone and Rituximab vs Fludarabine and Rituximab forRelapsed or Refractory Indolent NHLWithdrawnNCT00577161Phase 3
- CT-2103/Carboplatin vs Paclitaxel/Carboplatin for NSCLC in Women With Estradiol > 25 pg/mLWithdrawnNCT00576225Phase 3
- Carboplatin With Either Paclitaxel Poliglumex or Paclitaxel in Treating Women With Stage IIIB, Stage IV, or Recurrent Non-Small Cell Lung CancerTerminatedNCT00551733Phase 3
- Fludarabine and Rituximab With or Without Pixantrone in Treating Patients With Relapsed or Refractory Indolent Non-Hodgkin LymphomaWithdrawnNCT00551239Phase 3
- A Study of Palifermin for the Reduction of Oral Mucositis in Subjects With Locally Advanced Head and Neck Cancer Receiving Postoperative RadiotherapyWithdrawnNCT00540332Phase 1/2
- Efficacy and Tolerability of Novel A2A Agonist in Treatment of Diabetic Neuropathic PainCompletedNCT00452777Phase 2
- Palifermin DDI (Drug Drug Interaction)CompletedNCT00361348Phase 1
- PROMPT - Palifermin in Reduction of Oral Mucositis in PBSC TransplantationCompletedNCT00352703Phase 4
- CT-2106 for the Second Line Treatment of Ovarian CancerCompletedNCT00291837Phase 2
- Phase I/II CT 2106 and 5-FU/FA in Colorectal CancerCompletedNCT00291785Phase 1/2
- A Survival Study for Women With Advanced Lung Cancer Who Have Not Previously Received Chemotherapy.TerminatedNCT00269828Phase 3
- Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)CompletedNCT00106600Phase 1/2
- Pharmacokinetic Study of Palifermin in Subjects Receiving Radiation Therapy and Chemotherapy Followed by Blood Stem Cell SupportCompletedNCT00070616Phase 1
- Phase II CT-2103/Carboplatin in Ovarian CancerCompletedNCT00069901Phase 2
- Dose Ranging Trial for Pixantrone in the FND-R Variant Regimen in Indolent Non-Hodgkin's LymphomaCompletedNCT00060684Phase 1
- Comparative Trial for Pixantrone in Combination With Rituximab in Indolent Non-Hodgkin's LymphomaTerminatedNCT00060671Phase 3
- Polyglutamate Paclitaxel Plus Carboplatin Compared With Paclitaxel Plus Carboplatin in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054210Phase 3
- Polyglutamate Paclitaxel Compared With Gemcitabine or Vinorelbine in Treating Patients With Advanced or Recurrent Non-Small Cell Lung CancerTerminatedNCT00054197Phase 3
- Polyglutamate Paclitaxel Compared With Docetaxel in Treating Patients With Progressive Non-Small Cell Lung CancerTerminatedNCT00054184Phase 3
- Arsenic Trioxide in Treating Patients With Myelodysplastic SyndromesTerminatedNCT00020969Phase 2
- Arsenic Trioxide in Treating Patients With Multiple MyelomaTerminatedNCT00017433Phase 2
- Arsenic Trioxide and Dexamethasone in Treating Patients With Recurrent or Refractory Stage II or Stage III Multiple MyelomaTerminatedNCT00017069Phase 2
- CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous TherapyTerminatedNCT00004026Phase 2